Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Nitric oxide-based possibilities for pharmacotherapy

I Pörsti¹, I Paakkari

¹Department of Internal Medicine, Tampere University Hospital, Finland.

Annals of Medicine

|June 1, 1995

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The presence of intraperitoneal, retroperitoneal and pleural fluid in acute Puumala hantavirus infection.

Infectious diseases (London, England)·2022

Same author

Primary aldosteronism: Higher volume load, cardiac output and arterial stiffness than in essential hypertension.

Journal of internal medicine·2020

Same author

Corrigendum to "Celiac disease or positive tissue transglutaminase antibodies in patients undergoing renal biopsies" [Dig Liver Dis (2018);50:27-31].

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·2019

Same author

Effects of psychotropic drugs on digit substitution: comparison of the computerized symbol-digit substitution and traditional digit-symbol substitution tests.

Journal of psychopharmacology (Oxford, England)·2012

Same author

Glomerular filtration rate and parathyroid hormone are associated with 1,25-dihydroxyvitamin D in men without chronic kidney disease.

Journal of internal medicine·2011

Same author

High pentraxin-3 plasma levels associate with thrombocytopenia in acute Puumala hantavirus-induced nephropathia epidemica.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2011

Nitric oxide (NO) pharmacotherapy aims to balance NO metabolism for various conditions. Future therapies may involve targeted NO donors and selective enzyme inhibitors for improved efficacy and safety.

Area of Science:

Pharmacology
Biochemistry
Physiology

Background:

Nitric oxide (NO) plays a crucial role in physiological processes.
Dysregulation of NO metabolism is implicated in various diseases.
Current NO-based therapies primarily target cardiovascular conditions.

Purpose of the Study:

To explore the therapeutic potential of nitric oxide (NO) pharmacotherapy.
To discuss strategies for modulating NO levels in target tissues.
To review emerging applications and future directions in NO-based treatments.

Main Methods:

Direct administration of NO donors.
Indirect modulation of NO levels via L-arginine.
Pharmacological inhibition or induction of nitric oxide synthase (NOS) isoforms.

Related Experiment Videos

Inhalation of NO gas for respiratory conditions.

Main Results:

NO-based therapies are expanding beyond cardiovascular diseases to include sexual disorders, gastrointestinal issues, immunology, and tumor growth regulation.
Modulating NO levels can be achieved through various methods, including substrate availability and enzyme inhibition.
Inhaled NO offers targeted delivery to the respiratory system.
Potential challenges include the toxicity of NO donors and the formation of damaging radicals.

Conclusions:

Nitric oxide (NO) pharmacotherapy holds significant promise for a wide range of medical conditions.
Future research should focus on developing selective NOS isoform ligands and tissue-specific NO donors for controlled release.
Addressing the toxicity and radical formation associated with NO administration is critical for therapeutic advancement.